LinkMed AB (STO:LMED), a leading listed private equity company in the life science sector, is acquiring 100 percent of the shares in Olerup SSP AB, a world leading company in the transplantation area and one of Sweden’s most profitable biotechnology companies. The acquisition will further strengthen LinkMed’s position in the transplantation sector and is strategically important in that it complements LinkMed’s portfolio company AbSorber and its XM-ONE® product. In the long-term, LinkMed strives to build a larger company in the transplantation sector with a broad product portfolio. The value of the acquisition is SEK 216 million.
